Company Overview
- Headquarters
- 3960 Broadway, 6th Floor, New York NY
- Website
- stablix.com
- Employees
- 25
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Who is Stablix Inc
Stablix Inc. is a privately held biotechnology company based in New York City. The company employs 25 people and generates annual revenue exceeding $10,000. Stablix Inc. focuses on developing targeted deubiquitination therapeutics (TDT) designed to address unmet medical needs in various diseases. Their innovative approach aims to establish a novel small-molecule modality for treating a wide range of debilitating conditions. Stablix distinguishes itself through its pioneering research in deubiquitination therapeutics and its collaborative, multidisciplinary team of scientists, innovators, and leaders. Their commitment to transformative medicine drives their efforts to change the landscape of drug development. For more information, please visit Stablix Inc.'s website at stablix.com.
Company Leadership
Stablix Inc Industry Tags
Companies Similar to Stablix Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Stablix Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 18 | Arizona City, AZ | 1998 | |
| 10M | 9 | San Diego, CA | ||
| 10M | 6 | Campbell, CA | 2011 | |
| 10M | 2 | Torrington, WY | ||
| 10M | 1 | San Diego, CA | 2016 |